| Кадазолид | 1025097-10-2 | C29H29F2N3O8 | 5-гидроксииндол-3-уксусная кислота | 54-16-0 | C10H9NO3 | Dimethyl methylsuccinate | 1604-11-1 | C7H12O4 | 3,4,9,10-Perylenetetracarboxylic диимид | 81-33-4 | C24H10N2O4 | Роледумаб | 1174008-79-7 | | Cy5 DBCO chloride | 2182601-72-3 | C50H53ClN4O2 | Tesnatilimab (anti-NKG2D) | 2242758-08-1 | | 1-Вос-5-bromoindoline | 261732-38-1 | C13H16BrNO2 | Ранибизумаб | 347396-82-1 | C11H12N2O2 | LDC 000067 | 1073485-20-7 | C18H18N4O3S | WAY-327111 | 615273-95-5 | C15H14F3N3O | lineal alkylbenzene | 29986-57-0 | C18H30 | Datelliptium chloride hydrochloride | 157000-76-5 | C23H28ClN3O | Фланвотумаб | 1188277-05-5 | | WAY-326812 | 442898-48-8 | C24H28N4O2 | Галиксимаб | 357613-77-5 | | (S)-8-Bromochroman-4-amine hydrochloride | 1810074-67-9 | C9H11BrClNO | Mal-PEG1-NHS ester | 1807518-72-4 | C13H14N2O7 | 5-(hydroxyphenyl)-10,15,20-phenylporphyrin | 87345-22-0 | C44H30N4O | Amberlyst A21 free base | 9049-93-8 | C12H20O2 | Концизумаб | 1312299-39-0 | | Тесидолумаб | 1531594-08-7 | | Ксентузумаб | 1417158-65-6 | | Lacnotuzumab (anti-M-CSF) | 1831128-32-5 | | Ladiratuzumab (anti-SLC39A6) | 1629760-28-6 | | Narsoplimab (anti-MASP2) | 2108782-45-0 | | Fluorescein dibenzoate | 7262-40-0 | C34H20O7 | WAY-328173 | 912790-59-1 | C16H15ClN4O2 | WAY-327936 | 620103-74-4 | C11H7ClN2O2S3 | 10- [2-ДИЭТИЛАМИНОПРОПИЛ] ФЕНОТИАЗИН | 1094-08-2 | C19H25ClN2S | Эфир пинакола 2,2,2-трифторацетофенон-4-бороновой кислоты | 1004294-77-2 | C14H16BF3O3 | (R) - (-) -1,1 '-би (2-нафтол) бис (трифторметансульфонат) | 126613-06-7 | C22H12F6O6S2 | 8- (трифторметил) хинолин-5-карбоновая кислота | 253787-47-2 | C11H6F3NO2 | 4-Бром-2-фторбензальдегид | 57848-46-1 | C7H4BrFO | Chrysophenine | 2870-32-8 | C30H29N4NaO8S2 | (R) -1,2,3,9-ТЕТРАГИДРОПИРРОЛО [2,1-B] ХИНАЗОЛИН-3-OL ГИДРОХЛОРИД | 7174-27-8 | C11H13ClN2O | Tisotumab (anti-F3) | 1418628-81-5 | | Vopratelimab (anti-ICOS) | 2039148-04-2 | | Ragifilimab (anti-TNFRSF18) | 2207590-51-8 | | Strong acid cation exchange resin (NA) | 63182-08-1 | (C10H10)x.(C8H8O3S)x.xNa | Производная CTEP | 802906-73-6 | C18H13ClFN3 | Biotin-PEG2-acid | 1365655-89-5 | C17H29N3O6S | МЕТИЛ 2,4-ДИОКСО-4-ФЕНИЛБУТАНОАТ | 20577-73-5 | C11H10O4 | 3,5-Dimethyl-4-methoxybenzonitrile | 152775-45-6 | C10H11NO | Нарнатумаб | 1188275-92-4 | | WAY-330324 | 901031-81-0 | C23H20FN3O3 | (R)-STU104 | 2767124-77-4 | C18H18O4 | 4-Chloro-2,6-pyridinedicarboxylic Acid | 4722-94-5 | C7H4ClNO4 | BI-1015550 | 1423719-30-5 | C20H26ClN6O2S- | Могамулизумаб | 1159266-37-1 | | Beef extract desicxant | | | Росмантузумаб | 1684393-04-1 | | Ianalumab (anti-TNFRSF13C) | 1929549-92-7 | | Quetmolimab (anti-CX3CL1) | 2084037-83-0 | | 2,2-Dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | 20348-21-4 | C9H10N2O2 | Telazorlimab (anti-TNFRSF4) | 2126777-87-3 | | WAY-326432 | 870762-82-6 | C21H17F3N2O4 | Каннабидиварол | 24274-48-4 | C19H26O2 | Cesium hexafluorophosphate | 16893-41-7 | CsF6P | Apamistamab (anti-PTPRC) | 2097132-02-8 | | Sirtratumab (anti-SLITRK6) | 1824663-82-2 | | Nadecnemab (anti-GFRA3) | 2377679-19-9 | | 2-бромфенилуксусная кислота | 18698-97-0 | C8H7BrO2 | (2-Fluorophenyl)(2-(methylamino)-5-nitrophenyl)methanone | 735-06-8 | C14H11FN2O3 | Amberlite IRA-900 | 9050-97-9 | CH3BN- | Окселумаб | 1186098-83-8 | | Zagotenemab (anti-Tau) | 2019133-28-7 | | амилопектина | 9037-22-3 | C30H52O26 | Bexmarilimab (anti-STAB1) | 2259301-27-2 | | KWAR23 (anti-SIRPg) | 2243227-60-1 | | Лексатумумаб | 845816-02-6 | | 3-Fluoro-5-(trifluoromethyl)picolinonitrile | 80194-71-4 | C7H2F4N2 | tert-butyl (1R)-1-amino-3-azabicyclo[3.1.0]hexane-3-carboxylate | 1272757-54-6 | C10H18N2O2 | Bivatuzumab (anti-CD44v6) | 214559-60-1 | | Ravulizumab (anti-Complement C5) | 1803171-55-2 | | Methyl 6-hydroxy-5-nitronicotinate | 222970-61-8 | C7H6N2O5 | Лумиликсимаб | 357613-86-6 | | Ворсетузумаб | 1165740-62-4 | | Tamrintamab (anti-DPEP3) | 2148325-59-9 | | Cinpanemab (anti-Alpha-synuclein) | 2094516-02-4 | | Cy5.5 | 210892-23-2 | C41H44N2O14S4 | Idactamab (anti-SLC1A5) | 2245205-37-0 | | Tusamitamab (anti-CEACAM5) | 2349294-95-5 | | Д-циклосерин | 68-41-7 | C3H6N2O2 | DIPHENYLETHOXYMETHYLSILANE | 1825-59-8 | C15H18OSi | 6,7-Dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Perchlorate | 1334529-08-6 | C14H18ClN3O4 | 1,3-Циклогександикарбоновая кислота, (1R, 3R) -рел- | 2305-30-8 | C8H12O4 | Itolizumab (anti-CD6) | 1116433-11-4 | | WAY-333908 | 689269-24-7 | C21H29N3O4S | WAY-327360 | 687573-14-4 | C23H26N2O4S | 2′,7′-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein | 85138-49-4 | C27H20O11 | Sonepcizumab (anti-Sphingosine-1-phosphate) | 1031360-18-5 | | 10,13-диметил-17-оксо-3-сульфоокси-1,2,3,4,7,8,9,11,12,14,15,16-додекагидроциклопента[а]фенантрен | 651-48-9 | C19H28O5S | WAY-332068 | 1015864-69-3 | C19H24N2O3S | Gadolinium trihydride | 37280-14-1 | GdH2 | 1-метилпиридин-1-ий-3-карбоксамид | 3106-60-3 | C7H9N2O+ | WAY-332052 | 1015858-38-4 | C21H21FN2O3S | WAY-327449 | 693240-90-3 | C16H16N4O2 | Бимагрумаб | 1356922-05-8 | | Vandortuzumab (anti-STEAP1) | 1557989-52-2 | |